Clinical Trial Update: Intrapleural Urokinase for Retained Hemothorax [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intrapleural urokinase for retained hemothorax; the update does not provide results or status details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemothorax

Drugs mentioned

• Intrapleural urokinase (urokinase)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Retained Hemothorax | Phase 3 | Status: UNKNOWN